THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY
dc.authorwosid | Ongen, Zeki/AAD-1179-2021 | |
dc.authorwosid | Ongen, Zeki/HZL-8534-2023 | |
dc.authorwosid | ince, birsen/AAI-1704-2019 | |
dc.contributor.author | Marmarali, B. | |
dc.contributor.author | Ozdemir, O. | |
dc.contributor.author | Bozkurt, K. | |
dc.contributor.author | Demir, M. | |
dc.contributor.author | Ince, B. | |
dc.contributor.author | Kultursay, H. | |
dc.contributor.author | Ongen, G. | |
dc.date.accessioned | 2024-06-12T11:20:30Z | |
dc.date.available | 2024-06-12T11:20:30Z | |
dc.date.issued | 2013 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.doi | 10.1016/j.jval.2013.03.1480 | |
dc.identifier.endpage | A285 | en_US |
dc.identifier.issn | 1098-3015 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | A285 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jval.2013.03.1480 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/25647 | |
dc.identifier.volume | 16 | en_US |
dc.identifier.wos | WOS:000318916402439 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Value In Health | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY | en_US |
dc.type | Conference Object | en_US |